Enveric Biosciences Inc (ENVB)
0.98
+0.05
(+5.89%)
USD |
NASDAQ |
May 03, 16:00
0.9616
-0.02
(-1.88%)
After-Hours: 20:00
Enveric Biosciences Total Liabilities (Quarterly): 2.344M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.344M |
September 30, 2023 | 4.184M |
June 30, 2023 | 4.926M |
March 31, 2023 | 4.438M |
December 31, 2022 | 3.996M |
September 30, 2022 | 7.254M |
June 30, 2022 | 5.969M |
March 31, 2022 | 7.737M |
December 31, 2021 | 4.413M |
September 30, 2021 | 14.39M |
June 30, 2021 | 4.876M |
March 31, 2021 | 6.795M |
December 31, 2020 | 0.6813M |
September 30, 2020 | 14.82M |
June 30, 2020 | 14.63M |
March 31, 2020 | 16.91M |
December 31, 2019 | 14.38M |
September 30, 2019 | 13.41M |
June 30, 2019 | 18.62M |
March 31, 2019 | 19.34M |
December 31, 2018 | 18.88M |
September 30, 2018 | 15.81M |
June 30, 2018 | 27.24M |
March 31, 2018 | 28.75M |
December 31, 2017 | 32.75M |
Date | Value |
---|---|
September 30, 2017 | 34.92M |
June 30, 2017 | 33.67M |
March 31, 2017 | 34.91M |
December 31, 2016 | 27.84M |
September 30, 2016 | 33.37M |
June 30, 2016 | 12.73M |
March 31, 2016 | 13.43M |
September 30, 2015 | 20.25M |
June 30, 2015 | 9.318M |
March 31, 2015 | 0.0103M |
December 31, 2014 | 0.009M |
September 30, 2014 | 0.0023M |
June 30, 2014 | 0.002M |
March 31, 2014 | 0.0048M |
December 31, 2013 | 0.0247M |
September 30, 2013 | 0.0381M |
June 30, 2013 | 0.0353M |
March 31, 2013 | 0.0301M |
December 31, 2012 | 0.0257M |
September 30, 2012 | 0.0148M |
June 30, 2012 | 0.01M |
March 31, 2012 | 0.0098M |
December 31, 2011 | 0.0179M |
September 30, 2011 | 0.0077M |
June 30, 2011 | 0.0723M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6813M
Minimum
Dec 2020
18.62M
Maximum
Jun 2019
8.672M
Average
6.795M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
Seelos Therapeutics Inc | 38.93M |
Societal CDMO Inc (DELISTED) | 94.81M |
Cardiff Oncology Inc | 11.90M |
BioVie Inc | 14.00M |
Adial Pharmaceuticals Inc | 0.6531M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.300M |
Shareholders Equity (Quarterly) | 1.956M |